Estados financieros detallados de Can-Fite BioPharma Ltd. (CANF): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Can-Fite BioPharma Ltd. registró ingresos de $408212 en el último ejercicio fiscal, con un CAGR de 5 años del -11.8%.
Márgenes de los últimos 12 meses: margen bruto 100.0%, margen operativo -24.6%, margen neto -24.3%.
Al precio actual de $2.24, CANF presenta beneficios negativos (P/E no significativo) y un ROE del -201.06%. La capitalización bursátil es de $3M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $169500 | $844746 | $3.8M | $2.0M | $763000 | $853000 | $810000 | $743000 | $674000 | $408212 |
| Coste de Ventas | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $24190 |
| Beneficio Bruto | $169500 | $844746 | $3.8M | $2.0M | $763000 | $853000 | $810000 | $743000 | $674000 | $384022 |
| I+D | $6.1M | $5.3M | $6.1M | $11.0M | $12.0M | $9.8M | $7.8M | $6.0M | $5.8M | $6.7M |
| Generales y Administrativos | $2.7M | $2.9M | $3.2M | $3.1M | $3.0M | $3.8M | $3.1M | $3.0M | $3.0M | $3.7M |
| Gastos Operativos | $8.8M | $8.2M | $9.2M | $14.0M | $14.9M | $13.7M | $10.9M | $8.9M | $8.8M | $10.4M |
| Beneficio Operativo | -$8.6M | -$7.4M | -$5.4M | -$12.0M | -$14.1M | -$12.8M | -$10.1M | -$8.2M | -$8.1M | -$10.0M |
| EBITDA | -$8.7M | -$7.2M | -$6.1M | -$12.0M | -$14.1M | -$12.8M | -$10.1M | -$8.2M | -$8.1M | -$10.0M |
| Gastos por Intereses | $27296 | $1.1M | $1.2M | $427000 | $363000 | $18000 | $77000 | $14000 | $14000 | $14111 |
| Beneficio Antes de Impuestos | -$7.0M | -$5.0M | -$6.6M | -$12.6M | -$14.4M | -$12.6M | -$10.2M | -$7.6M | -$7.9M | -$9.9M |
| Impuestos | $29116 | $29922 | $4000 | $427000 | 0 | -$20000 | $360000 | 0 | 0 | 0 |
| Beneficio Neto | -$6.9M | -$5.0M | -$6.6M | -$12.6M | -$14.4M | -$12.6M | -$10.2M | -$7.6M | -$7.9M | -$9.9M |
| BPA | $-0.60 | $-0.38 | $-0.34 | $-0.30 | $-0.08 | $-0.06 | $-0.03 | $-0.01 | $-0.01 | $-0.08 |
| BPA Diluido | $-0.60 | $-0.38 | $-0.34 | $-0.30 | $-0.08 | $-0.06 | $-0.03 | $-0.01 | $-0.01 | $-0.08 |
| Acciones en Circulación (Diluidas) | $13.8M | $16.3M | $19.5M | $43.0M | $179.2M | $276.5M | $407.9M | $639.2M | $1.09B | $123.6M |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $8.1M | $3.5M | $3.6M | $2.7M | $8.3M | $4.4M | $3.0M | $4.3M | $4.8M | $5.5M |
| Inversiones a Corto | 0 | 0 | $273000 | $64000 | $75000 | $14.7M | $5.0M | $4.6M | $3.1M | $3.0M |
| Cuentas por Cobrar | $21837 | 0 | 0 | $637000 | $18000 | $48000 | $47000 | 0 | 0 | $73998 |
| Inventario | 0 | -$3.3M | -$4.0M | -$715000 | 0 | -$48000 | -$39000 | 0 | 0 | 0 |
| Activos Corrientes | $10.1M | $6.9M | $7.9M | $7.1M | $9.4M | $20.1M | $9.2M | $9.9M | $9.0M | $9.4M |
| Inmovilizado Material | $53293 | $46035 | $47000 | $118000 | $123000 | $185000 | $126000 | $81000 | $138000 | $73998 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $10.2M | $7.8M | $8.0M | $8.2M | $9.5M | $20.3M | $9.3M | $10.0M | $9.1M | $9.5M |
| Cuentas por Pagar | $1.2M | $427000 | $1.1M | $2.2M | $561000 | $954000 | $896000 | $427000 | $618000 | $1.2M |
| Deuda a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $2.5M | $1.8M | $3.1M | $3.3M | $1.3M | $2.7M | $2.5M | $2.0M | $2.1M | $2.7M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $6.3M | $4.8M | $4.9M | $5.7M | $3.4M | $5.9M | $4.8M | $3.7M | $3.7M | $3.9M |
| Reservas | -$91.0M | -$105.7M | -$100.6M | -$110.3M | -$125.5M | -$140.7M | -$150.8M | -$158.5M | -$166.4M | -$176.2M |
| Patrimonio Neto | $3.9M | $3.1M | $3.0M | $2.4M | $6.1M | $14.4M | $4.5M | $6.2M | $5.4M | $5.6M |
| Deuda Total | 0 | 0 | 0 | $75000 | $67000 | $124000 | $62000 | $40000 | $104000 | $70998 |
| Deuda Neta | -$8.1M | -$3.5M | -$3.9M | -$2.7M | -$8.3M | -$19.0M | -$7.9M | -$8.9M | -$7.8M | -$8.5M |
| Capital Circulante | $7.6M | $5.1M | $4.8M | $3.9M | $8.1M | $17.3M | $6.7M | $7.9M | $6.9M | $6.7M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Beneficio Neto | -$7.0M | -$5.0M | -$6.6M | -$12.6M | -$14.4M | -$12.6M | -$10.2M | -$7.6M | -$7.9M | -$9.8M |
| Amortizaciones | $18457 | $19852 | $14000 | $14000 | $12000 | $14000 | $14000 | $15000 | $7000 | $24190 |
| Compensación en Acciones | $309000 | $195074 | $535000 | $385000 | $355000 | $466000 | $263000 | $261000 | $362000 | $340000 |
| Cambio en Capital Circulante | -$449488 | -$2.4M | $1.1M | $1.2M | $2.0M | $2.4M | -$1.3M | -$943000 | -$267000 | $436434 |
| Flujo de Caja Operativo | -$8.9M | -$9.5M | -$4.2M | -$10.8M | -$12.1M | -$9.9M | -$10.8M | -$8.4M | -$7.6M | -$9.0M |
| Inversiones (CapEx) | -$10399 | -$6905 | -$33000 | -$3000 | -$26000 | -$11000 | -$9000 | -$2000 | -$5000 | -$2018 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$8.9M | -$9.5M | -$4.2M | -$10.8M | -$12.1M | -$9.9M | -$10.8M | -$8.4M | -$7.6M | -$9.0M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Crecimiento Ingresos (anual) | +398.4% | +352.2% | -46.8% | -62.5% | +11.8% | -5.0% | -8.3% | -9.3% | -39.4% | |
| Crecimiento Beneficio Neto (anual) | +28.0% | -32.2% | -92.1% | -14.4% | +12.8% | +19.2% | +25.0% | -3.2% | -25.7% | |
| Crecimiento BPA (anual) | +36.7% | +10.5% | +11.8% | +71.8% | +29.1% | +58.3% | +52.0% | +40.0% | -1013.9% | |
| Cambio en Acciones (anual) | +17.5% | +19.6% | +120.8% | +317.2% | +54.3% | +47.5% | +56.7% | +70.2% | -88.6% | |
| Crecimiento FCF (anual) | -6.6% | +56.1% | -158.8% | -11.6% | +18.4% | -9.5% | +21.9% | +9.5% | -18.1% | |
| Margen Bruto | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 94.1% |
| Margen Operativo | -5093.7% | -873.1% | -141.7% | -590.9% | -1853.1% | -1505.5% | -1246.4% | -1103.0% | -1206.2% | -2456.8% |
| Margen EBITDA | -5119.2% | -848.3% | -160.4% | -590.2% | -1851.5% | -1503.9% | -1244.7% | -1100.9% | -1205.2% | -2450.9% |
| Margen Neto | -4069.3% | -588.2% | -172.0% | -621.3% | -1892.9% | -1476.6% | -1255.9% | -1027.5% | -1169.1% | -2426.7% |
| Margen FCF | -5273.0% | -1128.2% | -109.6% | -533.3% | -1584.4% | -1157.0% | -1334.6% | -1136.2% | -1133.8% | -2210.1% |
| Tasa Impositiva Efectiva | -0.4% | -0.6% | -0.1% | -3.4% | -0.0% | 0.2% | -3.5% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| FCF por Acción | $-0.65 | $-0.59 | $-0.22 | $-0.25 | $-0.07 | $-0.04 | $-0.03 | $-0.01 | $-0.01 | $-0.07 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $13.8M | $16.3M | $19.5M | $43.0M | $170.8M | $229.4M | $407.9M | $639.2M | $1.09B | $123.6M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -201.06% |
| Rentabilidad sobre capital invertido | -145.49% |
| Rentabilidad sobre activos | -103.30% |
| Margen bruto | 100.00% |
| Margen operativo | -2456.79% |
| Margen neto | -2426.67% |
Salud financiera
| Deuda / Patrimonio | 0.01 |
| Ratio corriente | 3.46 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E | -11900.00 | -11684.21 | -11117.65 | -2200.00 | -4208.04 | -4300.00 | -4880.00 | -3666.67 | -4527.78 | -49.88 |
| P/VC | 25575.75 | 23644.10 | 24386.46 | 11609.44 | 10007.94 | 4115.92 | 11127.13 | 4504.78 | 6524.58 | 88.41 |
| P/V | 583261.50 | 85476.35 | 19247.43 | 13951.90 | 79670.05 | 69396.40 | 61432.75 | 37851.07 | 52622.56 | 1211.03 |
| Margen Bruto | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 94.1% |
| Margen Operativo | -5093.7% | -873.1% | -141.7% | -590.9% | -1853.1% | -1505.5% | -1246.4% | -1103.0% | -1206.2% | -2456.8% |
| Margen Neto | -4069.3% | -588.2% | -172.0% | -621.3% | -1892.9% | -1476.6% | -1255.9% | -1027.5% | -1169.1% | -2426.7% |
Empresas relacionadas: BDRX · CLDI · CMND · CNSP · GRI · JAGX · KZIA
Explorar sector: Healthcare · Biotechnology
Más secciones de CANF: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones